BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9229753)

  • 41. Predictors for prognosis of chronic myelocytic leukemia.
    Chen SS; Zhang HF; Xue WT; Li K; Wang P; Lui Y
    Chin Med J (Engl); 1993 Oct; 106(10):760-2. PubMed ID: 7913433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
    Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
    Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of HLA-DR negative B-precursor acute lymphoblastic leukemia.
    Giotopoulou S; Dokou E; Tzoufi M; Kolaitis N; Vartholomatos G
    J Exp Clin Cancer Res; 2003 Dec; 22(4):637-40. PubMed ID: 15053308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of primitive stem cell antigens on the blast cells of patients with chronic myeloid leukemia].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 1996; (3):9-13. PubMed ID: 8672965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diminished CD10, CD13, and CD15 expression in a differentiated granulocyte population in CML.
    Cruse JM; Lewis RE; Sanders CM; Webb RN; Beason KL; Lam J; Koehler J
    Exp Mol Pathol; 2007 Oct; 83(2):274-6. PubMed ID: 17662271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Extramedullary blast crisis in chronic myeloid leukemia].
    Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
    Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia].
    Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.
    Hernández JM; González-Sarmiento R; Martin C; González M; Sánchez I; Corral J; Orfao A; Cañizo MC; San Miguel JF; López-Borrasca A
    Br J Haematol; 1991 Nov; 79(3):408-14. PubMed ID: 1751368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome.
    Asgarian Omran H; Shabani M; Shahrestani T; Sarafnejad A; Khoshnoodi J; Vossough P; Faranoush M; Sharifian RA; Jeddi-Tehrani M; Rabbani H; Shokri F
    Iran J Immunol; 2007 Mar; 4(1):15-25. PubMed ID: 17652839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
    Martín-Henao GA; Quiroga R; Sureda A; García J
    Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphoblastic crisis of chronic myelogenous leukemia. Hand mirror variant.
    Kowal-Vern A; Birdsong BA; Dizikes G; Radvany R; Desai SN; Schumacher H
    Arch Pathol Lab Med; 1990 Jul; 114(7):676-8. PubMed ID: 2363626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Usefulness of monoclonal antibodies for immunophenotyping in leukemia].
    Sagawa K
    Nihon Rinsho; 1992 Jun; 50(6):1209-16. PubMed ID: 1518136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML).
    Lau RC; Squire J; Brisson L; Kamel-Reid S; Grunberger T; Dubé I; Letarte M; Shannon K; Freedman MH
    Leukemia; 1994 May; 8(5):903-8. PubMed ID: 8182949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population.
    Matolcsy A; Izer I; Magyarlaki T; Baranyay F
    Haematologia (Budap); 1991; 24(1):27-37. PubMed ID: 1813360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.